Tower Research Capital »

Citius Oncology shares owned by Tower Research Capital

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 12k 2.03
2024-12-31 $46 41 1.15
2024-09-30 $56 41 1.39

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Citius Oncology

Armistice Capital
Vanguard Group
Geode Capital Management
XTX Topco
Renaissance Technologies
State Street Corporation
IFP Advisors
Northern Trust
Citadel Advisors
Tower Research Capital
Advisor Group Holdings
Arkadios Wealth Advisors
UBS Group
Farther Finance Advisors

View all funds holding Citius Oncology